Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 213910

In scope icon L 5 A
QID 213910 (Type "213910" in App Search)
Figure A is a radiograph of a 70-year-old male smoker with a history of DVT presents to your office after undergoing a right reverse total shoulder arthroplasty (rTSA) 11 months ago for a 4-part proximal humerus fracture-dislocation. Prior to his surgery, he was diagnosed with a right partial rotator cuff tear and was being treated with corticosteroid injections for this, with the last one being 15 months ago. His initial postoperative course was uncomplicated. However, over the last 6 weeks, he has developed progressive right shoulder pain. He has peri-incisional erythema and elevated ESR/CRP. Which of the following is NOT a risk factor for this patient's current complication?
  • A

Coagulopathy

25%

353/1388

Proximal humerus fracture necessitating rTSA

21%

294/1388

Male

11%

150/1388

Smoking

3%

41/1388

Intra-articular steroid injection 4 months prior to surgery

39%

545/1388

  • A

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

The patient has developed a prosthetic joint infection (PJI) after his rTSA. Risk factors for PJI after TSA include coagulopathy, smoking, male, CSI within 3 months of surgery, TSA due to a fracture, revision TSA, ESRD, Lupus and rheumatoid arthritis (RA).

Periprosthetic shoulder infections are a major cause of revision after TSA with rates of 3-4%. They are more common to occur in the first 2 years and the most likely pathogen is P. Acnes (which is concentrated primarily in the axilla). P. Acnes requires incubation between 7-21 days prior to growth and as such, cultures are usually negative in the first 3-5 days. Methods to prevent shoulder PJI include antibiotic prophylaxis (clindamycin for P. acnes), hydrogen peroxide prep, using derma bond, and using silver-impregnated dressings. Treatment of shoulder PJI is similar to treatment of hip/knee PJI with the gold standard being a 2 stage revision and implant exchange.

Frangiamore et al. performed a prospective study on 33 patients with painful shoulder arthroplasty that required revision surgery, 11 of which were diagnosed as infected. The pre-operative intra-articular fluid was obtained and sent for α-defensin, which was compared to baseline data on normal α-defensin levels in the shoulder. Synovial α-defensin had sensitivity and specificity of 63% and 95% for PJI. The authors concluded that articular α-defensin was more effective than current diagnostic testing in predicting positive cultures and may be an effective adjunct in the workup of shoulder PJI.

Richards et al. performed a retrospective cohort study on 3906 patients who underwent primary TSA to determine the patient-specific risk factors for deep infection. The authors noted that male patients had a 2.5 increased likelihood of infection compared to females. Patients having a TSA after a fracture had a 3 fold higher risk of infection compared to elective TSAs. They noted that BMI, race, ASA score, and diabetes status were not associated with infection risk. They also found that P. Acnes was the most commonly cultured organism, accounting for 31% of isolates.

Werner et al. performed a retrospective database query of Medicare patients who underwent arthroplasty after ipsilateral shoulder injection to assess the risk of the timing of pre-operative intra-articular corticosteroid injections on the risk of post-operative infection. The authors created 3 arthroplasty cohorts: arthroplasty within 3 months of injection (n = 636), arthroplasty between 3 and 12 months after injection (n = 1573), and matched control arthroplasty (n = 6211). Infection rates within 3 and 6 months postoperatively were assessed. The incidence of infection after arthroplasty at 3 months (3.0%; OR, 2.0; P = .007) and 6 months (4.6%; OR, 2.0; P = .001) was significantly higher in patients who underwent injection within 3 months before arthroplasty compared with controls. The authors concluded that there was a significant increase in postoperative infection in Medicare patients who underwent injection within 3 months before shoulder arthroplasty. This association was not noted when shoulder arthroplasty occurred >3 months after injection.

Figure A: AP of the shoulder revealing a well-placed rTSA prosthesis.

Incorrect Answers:
Answer 1: There are several medical comorbidities that place a patient at increased risk for a shoulder PJI: coagulation, ESRD, Lupus, and RA.
Answer 2: A TSA placed for a fracture has a 3-fold increase in the rate of shoulder PJI compared to an elective TSA.
Answer 3: Males have a 2.5-fold increase rate of shoulder PJI compared to females.
Answer 4: Smokers have a significantly increased risk of shoulder PJI as compared to non-smokers.

REFERENCES (3)
Authors
Rating
Please Rate Question Quality

2.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(13)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options